1. Home
  2. SANG vs ELTX Comparison

SANG vs ELTX Comparison

Compare SANG & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sangoma Technologies Corporation

SANG

Sangoma Technologies Corporation

HOLD

Current Price

$4.62

Market Cap

163.0M

Sector

Technology

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

N/A

Current Price

$9.18

Market Cap

134.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SANG
ELTX
Founded
1984
2011
Country
Canada
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
163.0M
134.1M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
SANG
ELTX
Price
$4.62
$9.18
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$13.00
AVG Volume (30 Days)
5.5K
129.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.94
EPS
N/A
N/A
Revenue
N/A
$2,301,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.08
$4.60
52 Week High
$6.46
$12.62

Technical Indicators

Market Signals
Indicator
SANG
ELTX
Relative Strength Index (RSI) 43.95 58.99
Support Level $4.40 $8.76
Resistance Level $4.98 $9.25
Average True Range (ATR) 0.12 0.72
MACD -0.01 0.08
Stochastic Oscillator 40.00 68.90

Price Performance

Historical Comparison
SANG
ELTX

About SANG Sangoma Technologies Corporation

Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

Share on Social Networks: